{"record":{"code":"W-01633","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"NVS · SUB · EC · HOSPITAL EUGENIO ESPEJO","buyer":"","amount":376601.38,"currency":null,"records":2,"found":"2026-10-04","refs":["SICM-093-2022","ocds-5wno2w-CE-20240002555547-52558","ocds-5wno2w-CE-20240002572905-52558","2020-06-25","2016-03-23"],"id":"W-01633","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01633/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01633/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: subsidiary/issuer «NOVARTIS ECUADOR S.A.» ↔ SEC NVS (CIK 1114448, NOVARTIS AG): 2 non-competitive contracts at the buyer «HOSPITAL EUGENIO ESPEJO», 376,601 USD (≈ $376,601); method direct (Catálogo electrónico - Compra directa en el convenio SICM-093-2022, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA INCORPORACIÓN DE MEDICAMENTOS EN EL CATÁLOG; OCID ocds-5wno2w-CE-20240002555547-52558, ocds-5wno2w-CE-20240002572905-52558; ⚑ REPEAT: already sanctioned SEC by FCPA (2020-06-25 Novartis AG, 2016-03-23 Novartis AG); ↓ weak method (catalogue / exclusivity / accreditation / small purchase).","facts":[["Company / subject","NVS · SUB · EC · HOSPITAL EUGENIO ESPEJO",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","376,601",null],["Records behind the indicator","2",null],["Found","4 October 2026",null],["Code","W-01633",null],["Reference","SICM-093-2022",null],["Reference","ocds-5wno2w-CE-20240002555547-52558",null],["Reference","ocds-5wno2w-CE-20240002572905-52558",null],["Reference","2020-06-25",null],["Reference","2016-03-23",null]],"summary":"subsidiary/issuer «NOVARTIS ECUADOR S.A.» ↔ SEC NVS (CIK 1114448, NOVARTIS AG): 2 non-competitive contracts at the buyer «HOSPITAL EUGENIO ESPEJO», 376,601 USD (≈ $376,601); method direct (Catálogo electrónico - Compra directa en el convenio SICM-093-2022, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA INCORPORACIÓN DE MEDICAMENTOS EN EL CATÁLOG; OCID ocds-5wno2w-CE-20240002555547-52558, ocds-5wno2w-CE-20240002572905-52558; ⚑ REPEAT: already sanctioned SEC by FCPA (2020-06-25 Novartis AG, 2016-03-23 Novartis AG); ↓ weak method (catalogue / exclusivity / accreditation / small purchase)","entity":"4648e4ab"},"about":"Indicators computed from public data sets: contracts, payments, registers, trade and sanctions lists. An indicator is a reason to check, not a decision of a public authority.","evidence":[],"row":{"country":"Ecuador","iso2":"EC","part":"Findings","indicator":"Debarred / sanctioned abroad × US SEC issuer","about":"Indicators computed from public data sets: contracts, payments, registers, trade and sanctions lists. An indicator is a reason to check, not a decision of a public authority.","findings":84,"new_today":0,"on_pages":84,"full_list":[],"html":"https://worldwide-corruption.com/database/ecuador/findings/fcpa-pattern/","json":"https://worldwide-corruption.com/database/ecuador/findings/fcpa-pattern/index.json"},"other_records_of_this_company":[],"html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01633/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01633/index.json"}